AstraZeneca admits its COVID-19 vaccine CAUSES BLOOD CLOTS in U.K. court filings

We are building the infrastructure of human freedom and empowering people to be informed, healthy and aware. Explore our decentralized, peer-to-peer, uncensorable Brighteon.io free speech platform here. Learn about our free, downloadable generative AI tools at Brighteon.AI. Every purchase at HealthRangerStore.com helps fund our efforts to build and share more tools for empowering humanity with knowledge and abundance.

05/08/2024 / By Ava Grace

Anglo-Swedish drug manufacturer AstraZeneca has admitted in British court filings that its Wuhan coronavirus (COVID-19) injection can cause deadly blood clots.

AstraZeneca’s viral vector COVID-19 injection co-developed with the University of Oxford is sold under the brand names Covishield and Vaxzevria. But the injection was recalled in several countries due to the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) – blood clots coupled with a low blood platelet count.

While VITT has been accepted as a potential side effect for two years, the Telegraph reported that AstraZeneca’s recent admission was the first time it did so. According to the British newspaper, the admission arose from a class action lawsuit over claims that the vaccine caused death and serious injury in those injected with it.

Fifty-one cases have been lodged in the High Court of Justice in London, with Jamie Scott being the first vaccine victim to file. Victims and grieving relatives seeking damages estimated to be worth up to £100 million ($124.86 million). According to the Daily Expose, “AstraZeneca’s admission was made in a legal defense to Scott’s High Court claim.” (Related: AstraZeneca finally admits that their COVID-19 vaccine causes thrombosis with thrombocytopenia syndrome (TTS).)

The 47-year-old was left with a permanent brain injury following a blood clot and bleeding on the brain after getting the vaccine in April 2021. This vaccine injury has left him unable to work since. Prior to the admission, AstraZeneca told lawyers for Scott that they “do not accept that TTS [thrombosis with thrombocytopenia syndrome] is caused by the vaccine at a generic level.”

“I hope their admission means we will be able to sort this out sooner rather than later,” said Jamie’s wife Kate. “We need an apology, fair compensation for our family and other families who have been affected. We have the truth on our side, and we are not going to give up.”

AstraZeneca still insists that blood clots from its COVID-19 injection are “rare”

In the legal document submitted to the High Court in February and later obtained through a Freedom of Information request, the vaccine maker stated: “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known. Further, TTS can also occur in the absence of the AZ vaccine (or any vaccine). Causation in any individual case will be a matter for expert evidence.”

TTS is a medical condition where a person suffers blood clots along with a low amount of platelets – cells that typically help the blood to clot. But while lawyers for the claimants argue that VITT is a subset of TTS, AstraZeneca does not appear to recognize the term.

Lawyer Sarah Moore, who represents some of the victims of AstraZeneca’s COVID-19 injection, denounced the vaccine maker for its use of delaying tactics. She told the Telegraph: “Regrettably it seems that AstraZeneca, the British government and their lawyers are more keen to play strategic games and run up legal fees than to engage seriously with the devastating impact that their vaccine has had upon our clients’ lives.”

The repercussions of AstraZeneca’s admission has also reached India, a former colony of the British Empire. It led to questions over why New Delhi approved Covishield, the Indian version of AstraZeneca’s injection.

India reportedly received 1.75 billion doses of Covishield, according to Firstpost. The Serum Institute of India (SII) stopped manufacturing Covishield in December 2021, but resumed production in April 2023.

But Venugopalan Govindan, a father who lost his 20-year-old daughter Karunya in 2021 due to the Covishield injection, has announced plans to sue SII and AstraZeneca. According to Govindan, the vaccine maker’s admission about the side effect was “too late” and only came after “so many lives have been lost.”

Visit BigPharmaNews.com for similar stories.

Watch Clayton and Natali Morris discussing AstraZeneca’s admission that its COVID-19 injection can cause deadly blood clots in the clip below.

This video is from the Neroke-5 on channel on Brighteon.com.